Oliman, Zulma .
HRN: 21-46-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2022
CEFUROXIME 750MG (VIAL)
06/12/2022
06/18/2022
IV
335mg
Q8hrs
Pcap C With HRAd
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes